Greg Pyszczymuka

Greg Pyszczymuka discloses dealings in Aytu Biopharma, Inc to SEC (Form 4). In total, 13 filings cover trades dated from 19 December 2022 to 28 July 2026.

The open-market record is one-sided, with 2 purchases worth €44k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants and 9 option exercises.

The record was last updated on 30 July 2026 with a share grant in Aytu Biopharma, Inc. The clock since the last published purchase (20 June 2023) now reads 1,222 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.